Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics Licenses microRNA Genes from Rockefeller University

NEW YORK (GenomeWeb News) – Rosetta Genomics said today that it has licensed non-exclusive rights to microRNA genes for research applications from Rockefeller University.
 
The agreement covers viral and human microRNAs that Rosetta intends to add to its existing intellectual property portfolio, which currently includes two issued patents, two allowed patent applications, and 60 pending patent applications. The Rehovot, Israel-based firm previously licensed from Rockefeller rights to microRNAs for therapeutic and diagnostic uses.
 
Terms of the license were not disclosed.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.